Jeuveau™ (#NEWTOX)
What is this #NEWTOX I keep hearing about?
The Jeuveau™ launch campaign in the U.S. includes the promotional hashtag #NEWTOX. Jeuveau™ is a modern-made neurotoxin and the first and only neurotoxin dedicated exclusively to aesthetics.1,2 It is an injectable treatment approved by the FDA for the temporary improvement in the appearance of moderate to severe frown lines in adults.
- Aesthetics Only: Jeuveau™ is the first neurotoxin to come to market in almost a decade and the only dedicated exclusively to aesthetics.
- Modern-Made: Jeuveau™ is a modern-made neurotoxin, produced in a state-of-the-art facility using Hi-Pure™ technology.
- Clinically Proven: Jeuveau™ is backed by studies of more than 2,100 patients including two Phase III U.S. trials, the largest head-to-head trial versus Botox™ Cosmetic, as well as two long-term safety studies.
How does Jeuveau™ work?
Jeuveau™ is a prescription medicine that is injected into muscles and used in adults for a short period of time (temporary) to improve the look of moderate to severe frown lines between the eyebrows (glabellar lines).
What makes Jeuveau™ different? Why should I try it?
Launched in the US under the promotional hashtag #NEWTOX, Jeuveau™ is a modern-made neurotoxin and the first and only neurotoxin approved exclusively for aesthetics.1,2 There is a lot of excitement about Jeuveau™ as it’s the first neurotoxin to hit the U.S. market in almost a decade.2 Furthermore, Jeuveau™ has also been studied in the largest head-to-head clinical trial versus Botox™ Cosmetic.
We are one of the first practices to offer this exclusive treatment.
What are some of the potential side effects?
The most commonly reported side effects in clinical trials include headache, eyelid drooping, upper respiratory tract infection and increased white blood cell count.2 No serious drug-related events were observed in the studies.
